Basilea Pharmaceutica AG Allschwil BPMUF
$77.40
Last Updated: Aug 19, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
BPMUF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Basilea Pharmaceutica AG Allschwil is classified as halal.
HALAL
Report Source: undefined Quarter Report
Basilea Pharmaceutica AG Allschwil. Stock Analysis BPMUF
United States Health Care Small Cap Basilea Pharmaceutica AG engages in the discovery, development, and commercialization of pharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft and currently employs 189 full-time employees. The company went IPO on 2004-03-25. The firm operates in one segment, which is the discovery, development, and commercialization of pharmaceutical products to meet the needs of patients with severe bacterial and fungal infections. The company launched two hospital brands, Cresemba, which is an intravenous and oral drug for the treatment of invasive fungal infections, and Zevtera, which is an intravenous antibiotic for the treatment of severe bacterial infections, especially pneumonia. Additionally, the Company has several preclinical anti-infective assets in their portfolio. Company's products are present in United States, Canada, Europe, Asia, and Africa.
Basilea Pharmaceutica AG Allschwil (BPMUF) Chart
Financial Metrics & Statements of Basilea Pharmaceutica AG Allschwil (BPMUF)
FAQ's for Basilea Pharmaceutica AG Allschwil (BPMUF)
- As of August 2026, Basilea Pharmaceutica AG Allschwil BPMUF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Basilea Pharmaceutica AG Allschwil using these criteria to determine its compliance status.
- Muslim investors may consider investing in Basilea Pharmaceutica AG Allschwil if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Basilea Pharmaceutica AG Allschwil by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Basilea Pharmaceutica AG Allschwil may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Basilea Pharmaceutica AG Allschwil on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Basilea Pharmaceutica AG Allschwil (BPMUF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
